BIOTECH GROUP Elan expects revenue growth of as much as 17 per cent this year as sales growth of the Tysabri multiple sclerosis… BIOTECH GROUP Elan expects revenue growth of as much as 17 per cent ...
DUBLIN--(BUSINESS WIRE)-- Elan Corporation, plc (NYS: ELN) today issued a formal response document in respect of the Echo Pharma Acquisition Limited (Royalty Pharma) revised offer made on May 23, 2013 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback